# thrombocytosis-guide
This 2025 British Society for Haematology (BSH) guideline represents a   significant update addressing the diagnostic and therapeutic challenges of    thrombocytosis in patients lacking the classical myeloproliferative   neoplasm (MPN) driver mutations.
